PGAM1 Antibodies

Santa Cruz Biotechnology provides a broad selection of PGAM1 monoclonal antibodies for investigating phosphoglycerate mutase 1 (PGAM1) in various biological processes. Multiple experimental applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PGAM1 is a key enzyme in the glycolytic pathway, facilitating the conversion of 3-phosphoglycerate to 2-phosphoglycerate. PGAM1 plays a crucial role in cellular metabolism and energy production, making it essential for cell proliferation and survival. Dysregulation of PGAM1 has been implicated in various cancers, highlighting its importance as a potential therapeutic target. Research has shown PGAM1 to be involved in multiple cellular pathways beyond glycolysis, including cell cycle regulation and stress response mechanisms. Understanding PGAM1's diverse functions can provide critical insights into metabolic disorders and cancer development. Recent studies have revealed PGAM1's potential as a biomarker for disease progression and treatment response. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PGAM1's role in health and disease.